Speakers
Barbara Wirostko MD, a serial entrepreneur, is the CMO and Co-founder of Qlaris Bio as well as Co-founder and Medical Advisor to MyEyes. As a…
Read More
Dr. Heah is an accomplished executive who brings over two decades of drug development and commercial experience, focused primarily in gene therapy and ophthalmology. She…
Read More
Professor of Ophthalmology, Vice Chair of International Research and Academic Affairs, Director of Ophthalmic Vascular Diagnostic & Research Program at Mount Sinai Hospital, Icahn School…
Read More
Dr. Navratil has served as our chief development officer since April 2022. He previously served as our senior vice president, research and development since joining…
Read More
Abla Creasey is the Vice President of Therapeutics Development. In this capacity, she leads all programs in Translational and Clinical development, with a focus on…
Read More
Retinal specialist with both extensive basic science training, clinical trial experience and drug development experience in Big Pharma. Main research interest is macular diseases, including…
Read More
Dr. Sherif joined Oculis as CEO in 2017 from Novartis where he served as Entrepreneur in Residence at the Novartis Venture Fund and since 2022,…
Read More
Hannah H. Chang is a Managing Director at Platanus, a global evergreen investment fund. Dr. Chang leads the firm’s healthcare venture capital strategy, investing in…
Read More
Mark L. Baum is the founder, Chairman of the Board, and CEO of Harrow. For the 2014-2017 periods, Harrow (formerly Imprimis Pharmaceuticals) was named by…
Read More
Dr. Frank W. Bowden, III, is the founder of Bowden Eye & Associates, a successful integrated eye care practice which he established in Jacksonville, Florida…
Read More
Mr. Robert L. Davis has served as senior vice president, general counsel of Glaukos Corporation since August 2023, after also serving in the same position…
Read More
Jonathan Liu is Senior Director of Business Development at Topcon Healthcare responsible for corporate venture capital investments. He previously served as Global Director of Product…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")